Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is a medication approved for the treatment of type 2 diabetes. However, recent clinical trials have shown that semaglutide can also aid in weight loss. In fact, in 2021, the US Food and Drug Administration (FDA) approved semaglutide for chronic weight management in adults with a body mass index (BMI) of 27 kg/m² or greater...